Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


3rd Patient Adherence and Advocacy Summit

25 Feb 2013 - 26 Feb 2013 - PA, USA



Bookmark and Share


The 2nd Patience Adherence Summit was a huge success with overwhelmingly positive feedback and comments from the audience evals. Our vision for the 3rd Patience Adherence and Advocacy Summit is to incorporate more of a patient-centric, patient-empowered focus as well as patient advocacy. The event will be very engaging and participant-oriented. Real-world scenarios and case studies will be featured and the audience will be fully engaged in learning and discovering innovative ideas on how to address and aid in the remedy of this devestaing industry-wide problem.

KEY LEARNING OBJECTIVES

Gain insightful new ideas to help Pharma understand why working with advocacy organizations not only makes good business sense, but how a patient can benefit from this collaboration as well

Understand how significant mobile technologies and digital platforms play in the rising adherence rates and how to incorporate these tools into your marketing plans

Leverage opportunities to work with government and non-profit agencies to better facilitate patient access to treatment

Recognize that extrinsic motivators are only short-lived and intrinsic motivators must be targeted for long-term behavior change

Determine the pharma-specific perceptions and rules that impact how industry works with advocacy groups

Incorporate your adherence messages with push and pull marketing



Further information
Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!